Congratulations to students who contributed to the scientific life of our institute this summer!

RI-MUHC researcher Peter Siegel is co-leader

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!

David Labbé and Géraldine Merle are in the inaugural cohort awarded funding from the New Frontiers in Research Fund from the Canadian government

Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators

Four graduate students from the Research Institute of the McGill University Health Centre (RI-MUHC) are among the 16 from McGill to win 2019 Vanier Scholarships.

Immunotherapy has provided lung cancer patients with real hope of recovery

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

Along with traditional presentations, the first CRP 3-minute thesis competition!

RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung

Zeinab Sharifi, doctoral student at the RI-MUHC, advances to the regional level with her first-prize placement at McGill

Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago

“My research is focused on programs to help cancer survivors cope with uncertainty and fear of recurrence along with support in the return to work”

A reliable test for early detection of endometrial and ovarian cancers wins Québec Science’s 2018 Award for Discovery of the Year!

Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer

A research paper describing a texture-based model that predicts lung metastasis risk in soft-tissue sarcomas won its authors the...

Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer